Newtopia Past Earnings Performance
Past criteria checks 0/6
Newtopia has been growing earnings at an average annual rate of 8.6%, while the Healthcare industry saw earnings growing at 16.2% annually. Revenues have been growing at an average rate of 7% per year.
Key information
8.6%
Earnings growth rate
58.9%
EPS growth rate
Healthcare Industry Growth | -6.7% |
Revenue growth rate | 7.0% |
Return on equity | n/a |
Net Margin | -78.2% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Newtopia makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 8 | -6 | 5 | 2 |
31 Mar 24 | 9 | -6 | 5 | 2 |
31 Dec 23 | 10 | -7 | 6 | 2 |
30 Sep 23 | 11 | -5 | 6 | 3 |
30 Jun 23 | 11 | -6 | 7 | 4 |
31 Mar 23 | 11 | -7 | 8 | 4 |
31 Dec 22 | 11 | -8 | 8 | 4 |
30 Sep 22 | 10 | -8 | 9 | 4 |
30 Jun 22 | 11 | -7 | 8 | 3 |
31 Mar 22 | 11 | -7 | 8 | 3 |
31 Dec 21 | 10 | -8 | 9 | 3 |
30 Sep 21 | 11 | -9 | 10 | 3 |
30 Jun 21 | 10 | -9 | 10 | 4 |
31 Mar 21 | 10 | -9 | 10 | 3 |
31 Dec 20 | 11 | -8 | 9 | 3 |
30 Sep 20 | 10 | -9 | 9 | 3 |
30 Jun 20 | 9 | -9 | 8 | 3 |
31 Mar 20 | 8 | -10 | 7 | 3 |
31 Dec 19 | 6 | -10 | 7 | 3 |
30 Sep 19 | 5 | -9 | 5 | 2 |
30 Jun 19 | 5 | -8 | 5 | 2 |
31 Mar 19 | 4 | -7 | 5 | 2 |
31 Dec 18 | 3 | -6 | 4 | 2 |
31 Dec 17 | 2 | -8 | 6 | 2 |
Quality Earnings: NEWU is currently unprofitable.
Growing Profit Margin: NEWU is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NEWU is unprofitable, but has reduced losses over the past 5 years at a rate of 8.6% per year.
Accelerating Growth: Unable to compare NEWU's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NEWU is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.4%).
Return on Equity
High ROE: NEWU's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.